2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Balazy M et al. | Facile method for preparation of 2,3-dinor-6-keto PGF1 alpha, the major urinary metabolite of prostacyclin. | 1988 | Prostaglandins | pmid:3070630 |
Sun FF et al. | Preparation of two dinor-PGI2 metabolites from 6-keto-PGF1 alpha by Mycobacterium rhodochrous. | 1980 | Prostaglandins | pmid:6258195 |
Vesterqvist O and Gréen K | Development of a GC-MS method for quantitation of 2,3-dinor-6-keto-PGF1 alpha and determination of the urinary excretion rates in healthy humans under normal conditions and following drugs. | 1984 | Prostaglandins | pmid:6548317 |
Stichtenoth DO et al. | Increased total body synthesis of prostacyclin in rats with adjuvant arthritis. | 1995 Nov-Dec | Prostaglandins | pmid:8838242 |
Schaefer WR et al. | Urinary excretion of 2,3-dinor-6-keto-PGF1 alpha and 11-dehydro-TXB2 by the gravid spontaneously hypertensive rat. | 1996 | Prostaglandins | pmid:8875634 |
Neulen J et al. | Arachidonic acid metabolism and prostaglandin production by primate preimplantation blastocysts. | 1991 | Prostaglandins | pmid:1775634 |
Knapp HR and Salem N | Formation of PGI3 in the rat during dietary fish oil supplementation. | 1989 | Prostaglandins | pmid:2557651 |
Seyberth HW et al. | Excretion of primary prostanoids and their metabolites during acute volume expansion. | 1988 | Prostaglandins | pmid:3163156 |
Hamazaki T et al. | Urinary excretion of PGI2/3-M and recent N-6/3 fatty acid intake. | 1989 | Prostaglandins | pmid:2503856 |
Farker K et al. | Measurements of urinary prostaglandins in young ovulatory women during the menstrual cycle and in postmenopausal women. | 1997 | Prostaglandins | pmid:9373880 |
Grèen K et al. | Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol). | 1989 | Prostaglandins | pmid:2664901 |
McAdam BF et al. | Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. | 1999 | Proc. Natl. Acad. Sci. U.S.A. | pmid:9874808 |
Praticò D et al. | Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice. | 2001 | Proc. Natl. Acad. Sci. U.S.A. | pmid:11248083 |
Saareks V et al. | Opposite effects of nicotinic acid and pyridoxine on systemic prostacyclin, thromboxane and leukotriene production in man. | 2002 | Pharmacol. Toxicol. | pmid:12403056 |
Ylikorkala O et al. | Urinary prostacyclin and thromboxane metabolites in drinking pregnant women and in their infants: relations to the fetal alcohol effects. | 1988 | Obstet Gynecol | pmid:3275910 |
Rauramo I et al. | Prostacyclin and thromboxane in pregnant and nonpregnant women in response to exercise. | 1995 | Obstet Gynecol | pmid:7770249 |
Yuhki K et al. | [Prostaglandin I2 and its metabolites]. | 2010 | Nippon Rinsho | pmid:20960743 |
Goldberg MR et al. | Prostacyclin biosynthesis and platelet function in autonomic dysfunction. | 1985 | Neurology | pmid:3838109 |
Fitzgerald DJ et al. | Platelet activation in unstable coronary disease. | 1986 | N. Engl. J. Med. | pmid:3531859 |
Alessandrini P et al. | Thromboxane biosynthesis and platelet function in type I diabetes mellitus. | 1988 | N. Engl. J. Med. | pmid:3292913 |